Skip to main content
Top
Published in: Arthritis Research & Therapy 2/2011

Open Access 01-04-2011 | Research article

Association between the PTPN22+1858 C/T polymorphism and psoriatic arthritis

Authors: Kristina Juneblad, Martin Johansson, Solbritt Rantapää-Dahlqvist, Gerd-Marie Alenius

Published in: Arthritis Research & Therapy | Issue 2/2011

Login to get access

Abstract

Introduction

The purpose of the present study was to investigate the frequency of the PTPN22 +1858 C/T single nucleotide polymorphism (SNP) (rs 2476601), previously shown to be associated with several autoimmune diseases, in patients with psoriatic arthritis (PsA) in comparison with population based controls.

Methods

A total of 291 patients (145 male/146 female, mean age (± S.D.) 52.2 (± 13.1) years) with PsA were examined clinically, by standard laboratory tests and their DNA was genotyped for the SNP rs2476601 (PTPN22 +1858 C/T). Allelic frequencies were determined and compared with 725 controls.

Results

Carriage of the risk allele, PTPN22+1858T, showed a significant association with patients with PsA compared with controls (χ2 = 6.56, P = 0.010, odds ratio (OR) 1.49; 95% confidence interval (CI) 1.10 to 2.02). A significantly higher proportion of carriers of the risk allele (T) had significantly more deformed joints (n ± SEM) (5.9 ± 1.2 vs 2.8 ± 0.5; P = 0.005).

Conclusions

In this study the +1858T allele of the PTPN22 gene, known to be associated with several autoimmune diseases, was associated with PsA. The finding of significantly more joints with deformities among carriers of the T variant could indicate a more aggressive phenotype of disease.
Literature
1.
go back to reference Moll JMH, Wright V: Psoriatic Arthritis. Semin Arthritis Rheum. 1973, 3: 55-78. 10.1016/0049-0172(73)90035-8.CrossRef Moll JMH, Wright V: Psoriatic Arthritis. Semin Arthritis Rheum. 1973, 3: 55-78. 10.1016/0049-0172(73)90035-8.CrossRef
2.
go back to reference Helliwell PS: Established psoriatic arthritis: clinical aspects. J Rheumatol Suppl. 2009, 83: 21-23.CrossRef Helliwell PS: Established psoriatic arthritis: clinical aspects. J Rheumatol Suppl. 2009, 83: 21-23.CrossRef
3.
go back to reference Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H: The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991, 34: 1218-1227. 10.1002/art.1780341003.CrossRef Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H: The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991, 34: 1218-1227. 10.1002/art.1780341003.CrossRef
4.
go back to reference Alenius GM, Berglin E, Rantapää Dahlqvist S: Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis. 2006, 65: 398-400. 10.1136/ard.2005.040998.CrossRef Alenius GM, Berglin E, Rantapää Dahlqvist S: Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis. 2006, 65: 398-400. 10.1136/ard.2005.040998.CrossRef
5.
go back to reference Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielantes H, the CASPAR Study Group: Classification criteria for psoriatic arthritis. Development of new criteria from a large international study. Arthritis Rheum. 2006, 54: 2665-2673. 10.1002/art.21972.CrossRef Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielantes H, the CASPAR Study Group: Classification criteria for psoriatic arthritis. Development of new criteria from a large international study. Arthritis Rheum. 2006, 54: 2665-2673. 10.1002/art.21972.CrossRef
6.
go back to reference Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P: Genetics of psoriasis and psoriatic arthritis: Update and future discussion. J Rheumatol. 2008, 35: 1449-1453.PubMedPubMedCentral Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P: Genetics of psoriasis and psoriatic arthritis: Update and future discussion. J Rheumatol. 2008, 35: 1449-1453.PubMedPubMedCentral
7.
go back to reference Alenius GM: Psoriatic arthritis-new insights give new options for treatment. Curr Med Chem. 2007, 14: 359-366. 10.2174/092986707779941104.CrossRef Alenius GM: Psoriatic arthritis-new insights give new options for treatment. Curr Med Chem. 2007, 14: 359-366. 10.2174/092986707779941104.CrossRef
8.
go back to reference Moll JMH, Wright V: Familial occurrence of psoriatic arthritis. Ann Rheum Dis. 1973, 32: 181-201. 10.1136/ard.32.3.181.CrossRef Moll JMH, Wright V: Familial occurrence of psoriatic arthritis. Ann Rheum Dis. 1973, 32: 181-201. 10.1136/ard.32.3.181.CrossRef
9.
go back to reference Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattare P, Nika K, Tauts L, Taskén K, Cucca F, Mustelin T, Bottini N: Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of- fundcion variant. Nat Genet. 2005, 37: 1317-1319. 10.1038/ng1673.CrossRef Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattare P, Nika K, Tauts L, Taskén K, Cucca F, Mustelin T, Bottini N: Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of- fundcion variant. Nat Genet. 2005, 37: 1317-1319. 10.1038/ng1673.CrossRef
10.
go back to reference Arechiga AF, Habib T, He Y, Zhang X, Zhang Z-Y, Funk A, Buckner JH: Cutting edge: The PTPN22 allelic variant associated with autoimmuity impairs B cell signaling. J Immunol. 2009, 182: 3343-3347. 10.4049/jimmunol.0713370.CrossRef Arechiga AF, Habib T, He Y, Zhang X, Zhang Z-Y, Funk A, Buckner JH: Cutting edge: The PTPN22 allelic variant associated with autoimmuity impairs B cell signaling. J Immunol. 2009, 182: 3343-3347. 10.4049/jimmunol.0713370.CrossRef
11.
go back to reference Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Franco Meloni G, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004, 36: 337-338. 10.1038/ng1323.CrossRef Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Franco Meloni G, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004, 36: 337-338. 10.1038/ng1323.CrossRef
12.
go back to reference Begovich AB, Carlton VEH, Honigberg LA, Schrodi J, Chokkalingam AP, Alexander C, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SYP, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffrey DA, Lee AT, Batiwalia F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Snisky JJ, Gregersen PK: A Missense Single-nucleotide polymorphism in a gene encoding a protein phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004, 75: 330-337. 10.1086/422827.CrossRef Begovich AB, Carlton VEH, Honigberg LA, Schrodi J, Chokkalingam AP, Alexander C, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SYP, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffrey DA, Lee AT, Batiwalia F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Snisky JJ, Gregersen PK: A Missense Single-nucleotide polymorphism in a gene encoding a protein phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004, 75: 330-337. 10.1086/422827.CrossRef
13.
go back to reference Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S: The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther. 2007, 9: R56-10.1186/ar2214.CrossRef Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S: The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther. 2007, 9: R56-10.1186/ar2214.CrossRef
14.
go back to reference Hinks A, Barton A, John S, Bruce I, Hawkins C, Griffiths CEM, Donn R, Thomson W, Silman A, Worthington J: Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population. Arthritis Rheum. 2005, 52: 1694-1699. 10.1002/art.21049.CrossRef Hinks A, Barton A, John S, Bruce I, Hawkins C, Griffiths CEM, Donn R, Thomson W, Silman A, Worthington J: Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population. Arthritis Rheum. 2005, 52: 1694-1699. 10.1002/art.21049.CrossRef
15.
go back to reference Huffmeier U, Reis A, Steffens M, Lascorz J, Bohm B, Lohmann J, Wendler J, Traupe H, Kuster W, Wienker TF, Burkhardt H: Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis. J Invest Dermatol. 2006, 126: 936-938. 10.1038/sj.jid.5700179.CrossRef Huffmeier U, Reis A, Steffens M, Lascorz J, Bohm B, Lohmann J, Wendler J, Traupe H, Kuster W, Wienker TF, Burkhardt H: Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis. J Invest Dermatol. 2006, 126: 936-938. 10.1038/sj.jid.5700179.CrossRef
16.
go back to reference Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P: Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Res Ther. 2006, 8: R27-10.1186/ar1880.CrossRef Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P: Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Res Ther. 2006, 8: R27-10.1186/ar1880.CrossRef
17.
go back to reference Bennett PH, Burch TA: Population Studies of the Rheumatic Diseases. 1968, Amsterdam: Exerpta Medica Foundation, 456-457. Bennett PH, Burch TA: Population Studies of the Rheumatic Diseases. 1968, Amsterdam: Exerpta Medica Foundation, 456-457.
18.
go back to reference Romanus R, Ydén S: Pelvo-spondylitis ossificans: Rheumatoid or Ankylosing Spondylitis-A Roentgenological and Clinic Guide to its Early Diagnosis. 1955, Copenhagen: Munksgaard, 28-34. Romanus R, Ydén S: Pelvo-spondylitis ossificans: Rheumatoid or Ankylosing Spondylitis-A Roentgenological and Clinic Guide to its Early Diagnosis. 1955, Copenhagen: Munksgaard, 28-34.
19.
go back to reference Gregersen PK, Lee H-S, Batliwalla F, Begovich AB: PTPN22: Setting thresholds for autoimmunity. Seminars in Immunology. 2006, 18: 214-223. 10.1016/j.smim.2006.03.009.CrossRef Gregersen PK, Lee H-S, Batliwalla F, Begovich AB: PTPN22: Setting thresholds for autoimmunity. Seminars in Immunology. 2006, 18: 214-223. 10.1016/j.smim.2006.03.009.CrossRef
Metadata
Title
Association between the PTPN22+1858 C/T polymorphism and psoriatic arthritis
Authors
Kristina Juneblad
Martin Johansson
Solbritt Rantapää-Dahlqvist
Gerd-Marie Alenius
Publication date
01-04-2011
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2011
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3284

Other articles of this Issue 2/2011

Arthritis Research & Therapy 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.